Stockscreener 앱 받기
33.94
3.89%
1.27
시간 외 거래:
34.19
0.25
+0.74%
Cogent Biosciences Inc 주식(COGT)의 최신 뉴스
Assessing Cogent Biosciences (COGT) Valuation After A Strong Year And Recent Share Price Pullback - Yahoo Finance
Why is Cogent Biosciences stock up 4% today? By Investing.com - Investing.com Canada
Why is Cogent Biosciences stock up 4% today? - Investing.com
COGT Stock Chart | COGENT BIOSCIENCES INC (NASDAQ:COGT) - ChartMill
Cogent Biosciences (COGT) CEO Robbins gifts 320,000 shares in estate move - Stock Titan
COGT SEC FilingsCogent Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
A Look At Cogent Biosciences (COGT) Valuation After New APEX And JAK2 Data Presentations Are Announced - Sahm
Could 2026 Mark A Transformational Year For Cogent Biosciences? - RTTNews
Cogent Biosciences (NASDAQ: COGT) group reports 9,043,903 shares - Stock Titan
Cogent Biosciences Announces Presentations of Pivotal APEX Trial Data and JAK2 V617F Program at EHA Congress 2026 - Moomoo
Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress - The Manila Times
TradingKey - TradingKey
Cogent Biosciences (COGT) Receives a Rating Update from a Top Analyst - The Globe and Mail
Pier Capital LLC Buys Shares of 46,260 Cogent Biosciences, Inc. $COGT - MarketBeat
Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), OnKure Therapeutics (OKUR) and Cogent Biosciences (COGT) - The Globe and Mail
Cogent Biosciences, Inc. $COGT Shares Purchased by Vanguard Group Inc. - MarketBeat
LifeSci Capital Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $55 - Moomoo
Piper Sandler Maintains Cogent Biosciences(COGT.US) With Buy Rating, Maintains Target Price $52 - Moomoo
Cogent Biosciences (COGT) Valuation After Wider Q1 Loss And Bezuclastinib Regulatory Progress - Yahoo Finance
A Quick Look at Today's Ratings for Cogent Biosciences(COGT.US), With a Forecast Between $45 to $55 - Moomoo
A Look At Cogent Biosciences (COGT) Valuation After First Quarter Earnings Loss And Strong One Year Share Price Run - Sahm
H.C. Wainwright raises Cogent stock price target to $55 on cash runway - Investing.com UK
Understanding the Setup: (COGT) and Scalable Risk - Stock Traders Daily
Cogent Biosciences Reports Recent Business Highlights and First Quarter 2026 Financial Results - Investing News Network
Cogent Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Cogent Biosciences (NASDAQ:COGT) Posts Quarterly Earnings Results, Hits Expectations - MarketBeat
Cogent Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Bezuclastinib NDAs and cash into 2028 at Cogent Biosciences (NASDAQ: COGT) - Stock Titan
Cogent Biosciences 1Q 2026: Net loss $(97.4)M, EPS $(0.53) — 10-Q Summary - TradingView
Biotechnology company Cogent Biosciences, Inc.'s latest financial data shows that as of the end of the first quarter of 2026, the company held a total of $866.4 million in cash and cash equivalents. - Bitget
Cogent Biosciences (COGT) boosts cash to fund bezuclastinib NDAs and launch plans - Stock Titan
Cogent Biosciences Q1 net loss widens on higher expenses - TradingView
Cogent plans two bezuclastinib launches, says cash lasts into 2028 - Stock Titan
BRIEF-Cogent Biosciences Q1 Income From Operations USD -103.607 Million - TradingView
MSN Money - MSN
Pictet Asset Management Holding SA Boosts Holdings in Cogent Biosciences, Inc. $COGT - MarketBeat
Cogent Biosciences, Inc. (NASDAQ:COGT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Cogent Biosciences Inc (NASDAQ:COGT) Shows Bullish Technical Breakout Setup with High Scores - ChartMill
Systemic Mastocytosis (SM) Treatment Market 2026-2035: - GlobeNewswire
Systemic Mastocytosis (SM) Treatment Market 2026-2035: Industry to More Than Double in Size, Led by Sanofi, AdvaCare Pharma, and Cogent Biosciences - Yahoo Finance
Teachers Retirement System of The State of Kentucky Invests $1.33 Million in Cogent Biosciences, Inc. $COGT - MarketBeat
Cogent Biosciences, Inc. (NASDAQ:COGT) Sees Large Drop in Short Interest - MarketBeat
Cogent Biosciences (COGT) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Cogent Biosciences prices equity offering and 1.625% convertible senior notes - MSN
COGT Rise as FDA Accepts Bezuclastinib NDA in Non-Advanced SM - MSN
A Look At Cogent Biosciences (COGT) Valuation After New KRAS And ErbB2 Data At AACR 2026 - Sahm
The Technical Signals Behind (COGT) That Institutions Follow - Stock Traders Daily
[ARS] Cogent Biosciences, Inc. SEC Filing - Stock Titan
0.98%
0.12%
자본화:
|
볼륨(24시간):